|
Title
|
|
|
|
Targeting ferroptosis to iron out cancer
|
|
|
Author
|
|
|
|
|
|
|
Abstract
|
|
|
|
| One of the key challenges in cancer research how to effectively kill cancer cells while leaving the healthy cells intact. Cancer cells often have defects in cell death executioner mechanisms, which is one of the r. An reasons for therapy resistance. To enable growth, cancer cells exhibit an increased iron demand compared with normal, non-cancer cells. This iron dependency can make cancer cells more vulnerable to iron-catalyzed necrosis, referred to as ferroptosis. The identification of FDA-approved drugs as ferroptosis inducers creates high expectations for the potential of ferroptosis to be a new promising way to kill therapy-resistant cancers. |
|
|
|
Language
|
|
|
|
English
|
|
|
Source (journal)
|
|
|
|
Cancer cell. - Cambridge, Mass.
|
|
|
Publication
|
|
|
|
Cambridge
:
Cell press
,
2019
|
|
|
ISSN
|
|
|
|
1535-6108
|
|
|
DOI
|
|
|
|
10.1016/J.CCELL.2019.04.002
|
|
|
Volume/pages
|
|
|
|
35
:6
(2019)
, p. 830-849
|
|
|
ISI
|
|
|
|
000470851400005
|
|
|
Pubmed ID
|
|
|
|
31105042
|
|
|
Full text (Publisher's DOI)
|
|
|
|
|
|
|
Full text (publisher's version - intranet only)
|
|
|
|
|
|